Medi Assist Healthcare Services Ltd Stock Falls to 52-Week Low of Rs.335.05

3 hours ago
share
Share Via
Medi Assist Healthcare Services Ltd’s shares declined sharply to a new 52-week low of Rs.335.05 on 4 March 2026, marking a significant drop amid a prolonged downtrend. The stock has now recorded losses for nine consecutive sessions, cumulatively falling by 18.11% over this period, underperforming its sector and broader market indices.
Medi Assist Healthcare Services Ltd Stock Falls to 52-Week Low of Rs.335.05

Stock Price Movement and Market Context

On the day in question, Medi Assist Healthcare Services Ltd’s stock touched an intraday low of Rs.335.05, representing a 5.82% decline from the previous close. This new low also stands as the all-time lowest price for the stock. The day’s performance saw the stock underperform its sector, the miscellaneous segment within insurance, which itself declined by 2.68%. The stock’s day change was recorded at -4.44%, further emphasising the downward pressure.

The broader market environment was mixed. The Sensex opened sharply lower by 1,710.03 points but managed a partial recovery, closing at 78,758.03, down 1.85% for the day. Notably, the Sensex was trading below its 50-day moving average, though the 50DMA remained above the 200DMA, indicating some underlying market resilience. Other indices such as NIFTY Realty and S&P BSE Realty also hit new 52-week lows on the same day, reflecting sector-specific pressures.

Technical Indicators and Moving Averages

The stock’s technical positioning remains weak. Medi Assist Healthcare Services Ltd is trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling sustained bearish momentum. This comprehensive weakness across short, medium, and long-term averages underscores the stock’s current downtrend and the absence of immediate technical support levels.

Performance Over the Past Year

Over the last 12 months, the stock has delivered a negative return of 24.62%, significantly lagging the Sensex’s positive 7.88% gain over the same period. This underperformance extends beyond the one-year horizon, with the stock also trailing the BSE500 index over the last three years, one year, and three months. The 52-week high for the stock was Rs.594.40, highlighting the steep decline from its peak to the current low.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Financial Performance and Profitability Metrics

The company’s recent quarterly financials have contributed to the subdued sentiment. Profit Before Tax (PBT) for the quarter stood at Rs.15.11 crores, reflecting a decline of 23.9% compared to the average of the previous four quarters. Net Profit After Tax (PAT) was Rs.11.11 crores, down 45.4% relative to the prior four-quarter average. Interest expenses reached a quarterly high of Rs.8.39 crores, adding to cost pressures.

Despite these declines, the company has maintained a Return on Equity (ROE) of approximately 14.05%, indicating a degree of fundamental strength. However, the stock’s valuation remains relatively expensive, trading at a Price to Book Value ratio of 4.6. This valuation is at a discount compared to the historical averages of its peers, but still reflects a premium given the recent earnings contraction.

Sector and Peer Comparison

Within the insurance sector, Medi Assist Healthcare Services Ltd’s performance has been below par in both the near and long term. The stock’s Mojo Score currently stands at 23.0, with a Mojo Grade of Strong Sell as of 2 December 2025, an upgrade from the previous Sell rating. The Market Cap Grade is rated at 3, indicating a mid-tier market capitalisation relative to peers. The stock’s underperformance relative to the sector and broader market indices highlights ongoing challenges in maintaining investor confidence.

Valuation and Market Capitalisation

The company’s market capitalisation and valuation metrics suggest a cautious stance among market participants. While the stock is trading at a discount to its peers’ historical valuations, the combination of declining quarterly profits and elevated interest costs has weighed on sentiment. The stock’s consistent decline over the past nine trading sessions and its position below all major moving averages reinforce the current bearish trend.

Holding Medi Assist Healthcare Services Ltd from Insurance? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Summary of Key Concerns

The stock’s fall to a new 52-week low is driven by a combination of factors including a sustained decline in quarterly profits, rising interest expenses, and a valuation that remains elevated relative to earnings performance. The prolonged nine-day losing streak and the stock’s position below all major moving averages reflect persistent downward momentum. Additionally, the stock’s underperformance relative to the Sensex and its sector peers over multiple time frames highlights ongoing challenges in regaining market favour.

Long-Term Fundamental Strength

Despite recent setbacks, Medi Assist Healthcare Services Ltd retains a degree of fundamental strength, as evidenced by its average ROE of 14.05%. This suggests the company continues to generate reasonable returns on equity capital, which may provide some stability amid the current price weakness. However, the recent financial results and market valuation indicate that the stock is currently navigating a challenging phase.

Conclusion

The decline of Medi Assist Healthcare Services Ltd’s stock to Rs.335.05 marks a significant milestone in its recent price trajectory, reflecting a combination of subdued earnings, elevated costs, and technical weakness. While the company maintains solid long-term fundamentals, the current market environment and financial metrics have contributed to a cautious outlook. The stock’s performance relative to its sector and broader market indices underscores the challenges faced in reversing the downtrend.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News